Nanoviricides Inc (NNVC)
1.20
+0.05
(+4.35%)
USD |
NYAM |
Apr 25, 10:36
Nanoviricides Shares Outstanding: 11.78M for Feb. 14, 2024
Shares Outstanding Chart
Historical Shares Outstanding Data
Date | Value |
---|---|
February 14, 2024 | 11.78M |
December 31, 2023 | 11.78M |
November 14, 2023 | 11.75M |
November 13, 2023 | 11.57M |
October 10, 2023 | 11.75M |
September 30, 2023 | 11.75M |
July 31, 2023 | 11.70M |
June 30, 2023 | 11.70M |
May 15, 2023 | 11.67M |
May 05, 2023 | 11.67M |
March 31, 2023 | 11.67M |
February 14, 2023 | 11.64M |
December 31, 2022 | 11.63M |
November 14, 2022 | 11.61M |
October 17, 2022 | 11.61M |
October 13, 2022 | 11.59M |
September 30, 2022 | 11.61M |
June 30, 2022 | 11.59M |
May 16, 2022 | 11.55M |
March 31, 2022 | 11.55M |
February 14, 2022 | 11.53M |
December 31, 2021 | 11.53M |
November 12, 2021 | 11.52M |
October 12, 2021 | 11.52M |
September 30, 2021 | 11.53M |
Date | Value |
---|---|
September 27, 2021 | 11.52M |
June 30, 2021 | 11.52M |
May 14, 2021 | 11.50M |
March 31, 2021 | 11.50M |
February 15, 2021 | 10.68M |
December 31, 2020 | 10.68M |
November 14, 2020 | 10.66M |
October 14, 2020 | 10.65M |
October 09, 2020 | 10.65M |
September 30, 2020 | 10.67M |
July 31, 2020 | 10.66M |
July 10, 2020 | 10.65M |
July 09, 2020 | 9.073M |
July 08, 2020 | 9.073M |
June 30, 2020 | 9.083M |
June 22, 2020 | 9.073M |
May 22, 2020 | 9.092M |
May 21, 2020 | 7.692M |
March 31, 2020 | 7.673M |
March 23, 2020 | 7.603M |
February 14, 2020 | 7.423M |
January 29, 2020 | 7.423M |
January 25, 2020 | 6.746M |
January 13, 2020 | 3.854M |
December 31, 2019 | 3.871M |
Shares Outstanding Definition
The volume of stock shares issued by the company and in the hands of the public. This number entails how much is being traded in the open market. A decreasing shares outstanding over time may be the result of company buybacks. Companies frequently make stock buybacks and retire those buybacks as treasury stock.
Shares Outstanding Range, Past 5 Years
3.837M
Minimum
May 15 2019
11.78M
Maximum
Feb 14 2024
9.492M
Average
11.09M
Median
Shares Outstanding Benchmarks
Gilead Sciences Inc | 1.246B |
NovaBay Pharmaceuticals Inc | 30.10M |
Palatin Technologies Inc | 16.14M |
iBio Inc | 3.484M |
Theriva Biologics Inc | 17.15M |